Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline fosamil in S. aureus and MRSA Bacteremia
NCT01701219Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Jan 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftaroline fosamil in Staphylococcus aureus bacteremia (SAB), sponsored by Forest Laboratories. Started Jan 2013; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT01701219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01701219.